Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer

Clinical trial NCT03571126 · UNKNOWN

Trial details

NCT number: NCT03571126
Sponsor: Zunyi Medical College
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Chemotherapy-induced Nausea and Vomiting Lung Cancer

Start date: 2019-05-09
Primary completion: 2022-10-01
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.